Viewing Study NCT01571232


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-02-22 @ 7:28 PM
Study NCT ID: NCT01571232
Status: COMPLETED
Last Update Posted: 2021-03-30
First Post: 2012-04-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Sponsor: Retina Macula Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Macular Edema View
None Non-proliferative Diabetic Retinopathy View
None Proliferative Diabetic Retinopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Macular Edema View
None DME View
None PDR View
None NPDR View
None Ozurdex View
None Dexamethasone View
None Avastin View
None Bevacizumab View